• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Vaxart

edit

Vaxart is a privately held biotechnology company near UCSF Mission Bay in San Francisco. Their mission is to develop rapid and efficient vaccine technology to fight infectious diseases.

Vaxart was founded in 2004 and has filed patents covering its novel platform technology for vaccination using vectors together with TLR ligands.

Recent Milestones

edit

• 
  Vaxart received $9M in Series B funding. (3/4/10)
  Posted 3/4/10 at 2:48pm via thefreelibrary.com
• 
  Vaxart received $3.5M in Series B funding. (1/14/10)
  Posted 1/20/10 at 7:58pm via venturebeat.com
• 
  Vaxart received $3.3M in Series A funding. (11/15/07)
  Posted 7/14/09 at 4:50am via vaxart.com

Videos

Screenshots

edit

Above: Vaxart
Uploaded: 7/14/09

Sources

1. VAXART COMPLETES SERIES A FINANCING (vaxart.com) [edit]
2. Vaxart gets $3.5M injection to make vaccinations oral (deals.venturebeat.com) [edit]
3. Vaxart Raises $12.5M in Series B to Take Oral Vaccine into Clinic. (thefreelibrary.com) [edit]